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ABSTRACT
Drimia elata is an important and well-known medicinal plant in tropical Africa. This study critically reviewed the medicinal applications, 
phytochemistry, and pharmacological activities of D. elata. Literature on medicinal applications, phytochemical, and pharmacological activities of 
D. elata was collected from multiple internet sources including Elsevier, Google Scholar, SciFinder, Web of Science, PubMed, BMC, ScienceDirect, 
and Scopus. Complementary information was gathered from pre-electronic sources such as books, book chapters, theses, scientific reports, and 
journal articles obtained from the university library. This study showed that D. elata is used for treating several medical conditions, particularly 
general ailments, blood and cardiovascular system, reproductive system and sexual health, urinary system, infections and infestations, digestive 
system, respiratory system, and muscular-skeletal system disorders. Phytochemical compounds identified from the species include bufadienolides, 
alkaloids, aromatic acids, flavonoids, phlobatannins, saponins, steroids, tannins, and terpenoids. Ethnopharmacological research revealed that 
D. elata extracts have acetylcholinesterase enzyme inhibitory, antibacterial, antifungal, antimycobaceterial, anticancer, anti-inflammatory, antioxidant, 
hemagglutinating, and cytotoxicity activities. D. elata should be subjected to extensive in vivo experiments and also future studies should focus on how 
potential toxic components of the species can be managed when it is used as herbal medicine.
Keywords: Asparagaceae, Drimia elata, Herbal medicine, Tropical africa.
INTRODUCTION
Drimia elata Jacq. is an important and well-known medicinal plant 
in South Africa. Van et al.[1] provide an excellent introduction to 
the ethnopharmacological properties of D. elata and several other 
important medicinal plants in South Africa. D. elata is an ingredient 
of at least two traditional herbal concoctions in South Africa, known 
as “imbizae phuzwato” and “intelezi” that are sold commercially in the 
country. A herbal tonic, imbizae phuzwato is made from a mixture of 
roots, bulbs, rhizomes, and leaves of Acokanthera oppositifolia (Lam.) 
Codd, Aster bakeranus Burtt Davy ex C.A. Sim., Corchorus asplenifolius 
Burch., Cyrtanthus obliquus (L.f.) Aiton, Fusifilum physodes (Jacq.) 
Raf. ex Speta, Eriosema cordatum E.Mey., Gnidia kraussiana Meisn. 
var. kraussiana, Gomphocarpus fruticosus (L.) W.T. Aiton, Gunnera 
perpensa L., Hypericum aethiopicum Thunb., Ledebouria spp., 
Lycopodium clavatum L., Momordica balsamina L., Rubia cordifolia L., 
Scadoxus puniceus (L.) Friis and Nordal, Stephania abyssinica (Quart.-Dill. 
and A. Rich.) Walp., Tetradenia riparia (Hochst.) Codd, Vitellariopsis 
marginata (N.E.Br.) Aubrév, Watsonia densiflora Bak., and Zanthoxylum 
capense (Thunb.) Harv. [2,3]. The concoction is used as an energizing and 
detoxifying tonic used against general body pains, stress, constipation, 
arthritis, kidney problems, high blood pressure, and to increase sexual 
prowess [2,3]. D. elata is also an ingredient of “intelezi,” whose plant 
species composition varies from region to region of South Africa. 
Intelezi is used to protect households from evil spirits and lightning, and 
also to chase away, ward off or root out evil spirits [4].
D. elata is the third most popular bulbous medicinal plant used in South 
African traditional therapy [5] and is one of the topmost wild-harvested 
species sold in the informal economy trade in the Eastern Cape [6,7], 
Gauteng [8-10], KwaZulu-Natal [8,11], Limpopo [12], and the Western 
Cape [7,13,14] provinces in South Africa. Research by Ndawonde 
et al. [15] showed that D. elata bulb was sold by >50.0% of the traders 
in KwaZulu-Natal Province, while Philander et al. [14] revealed that 
bulbs of the species were sold by 35% of the traders in the Western 
Cape province, with 60.48 kg of the bulb fetching US$26.21. Earlier 
research by Dold and Cocks [6] revealed that D. elata is among the most 
frequently traded species in the Eastern Cape Province with 113.9 kg 
as the mean quantity traded per trader per annun with a kilogram of 
the bulb fetching US$3.36. Marshall [16] argued that D. elata is scarce 
and heavily traded in South Africa, characterized by a high monetary 
value in the country. Due to increasing demand for the species, D. elata 
is managed in herbal medicine home gardens in the Eastern Cape [17], 
Limpopo [18-20], and the Western Cape [14] provinces. Research 
by Wiersum et al. [17] revealed that D. elata is among the ten most 
frequently cultivated herbal medicines in medicinal home gardens in 
the Eastern Cape Province. It is, therefore, within this context that the 
current study was undertaken aimed at summarizing the medicinal uses, 
phytochemical, and ethnopharmacological properties of D. elata so as to 
evaluate its therapeutic importance throughout its distributional range.
BOTANICAL PROFILE AND DESCRIPTION OF D. ELATA
The genus Drimia Jacq. is a large group of deciduous geophytes 
belonging to the family Asparagaceae, previously included in the 
Hyacinthaceae family. The family of Hyacinthaceae is divided into four 
monophyletic subfamilies, namely Hyacinthoideae, Ornithogaloideae, 
Oziroeoideae, and Urginoideae [21]. At present, this family is considered 
as a subfamily Scilloideae in the expanded Asparagaceae sensu [22,23]. 
The species in each subfamily synthesize specialized secondary 
metabolites with Hyacinthoideae synthesizing homoisoflavanones 
and triterpenoids, Ornithogaloideae (cardenolides and steroidal 
glycosides), and Urgineoideae synthesizing bufadienolides [21]. The 
subfamily Urgineoideae has flat or winged seeds characterized by brittle, 
loosely adhering test a comprising genera Bowiea Harv. ex Hook. f. and 
Drimia [24].The genus Drimia is described by Manning et al. [24,25] in 
an inclusive and broad sense, including genera such as Litanthus Harv., 
Mucinea M. Pinter et al., Rhadamanthus Salisb., Rhodocodon Baker, 
Sagittanthera Mart-Azorín et al., Thuranthos C. H. Wright, Tenicroa 
Raf., and Urginea Steinh. The taxonomy of genus Drimia has always 
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2019.v12i4.30963
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been difficult with several species treated under genus Urginea until 
Jessop [26] reduced Urginea to a synonym of Drimia. The genus consists 
of about 100 bulbous species distributed in Southern Africa through 
tropical Africa to the Mediterranean, Asia, and Madagascar [24]. 
Synonyms of D. elata include D. alta R.A. Dyer, D. ciliaris Jacq. ex Willd., 
D. purpurascens J. Jacq., D. robusta Baker, D. villosa (Lindl.) Kunth, 
D. zombensis Baker, Idotheaelata Kunth, I. ciliaris (Jacq. ex Willd.) Kunth, 
I. purpurascens (J. Jacq.) Kunth, I. robusta (Baker) Kuntze, and I. villosa 
(Lindl.) Kunth [1,27-31].
D. elata is a geophyte with large underground bulb, strap-shaped 
leaves and long, slender flowering stalk which grows up 1.8 m in 
height [1,27-29,31]. The flowers are tubular, whitish to purple in color 
with the tips of the petals characteristically reflexed and the stamens 
fused into a narrow tube [1]. D. elata has been recorded in grassland, 
often among rocks at an altitude ranging from 15 m to 1650 m above 
sea level [29]. The species has been recorded in Botswana, Angola, 
Malawi, Kenya, South Africa, Swaziland, Zambia, South Sudan, Tanzania, 
Sudan, Uganda, Zimbabwe, and Mozambique [1,27-31](Fig. 1).
MEDICINAL USES OF D. ELATA
The medicinal applications recorded from literature were classified 
into ten medical categories following the Economic Botany Data 
Collection Standard [32] with some changes proposed by Macía 
et al. [33] and Gruca et al. [34]. This review showed that D. elata is 
used for treating several medicinal conditions, particularly general 
ailments, blood and cardiovascular system, reproductive system and 
sexual health, urinary system, infections and infestations, digestive 
system, respiratory system, and muscular-skeletal system disorders 
(Fig. 2). D. elata is used as herbal medicine against three out of five 
diseases categorized by the World Health Organization (WHO) as the 
top five killer diseases in sub-Saharan Africa in 2012. These diseases 
include human immunodeficiency virus/acquired immune deficiency 
syndrome (HIV/AIDS), lower respiratory tract infections, and diarrheal 
diseases [35]. Most medicinal uses are linked to the bulb and leaf or the 
entire plant in ritual or magical uses, and the species is also used mixed 
with other plant species (Table 1). Research by Gurib-Fakim [36] and 
Maroyi [37,38] revealed that traditional medicines are often prepared 
by combining several different plant species to effect synergistic 
properties or to initiate an interaction with a relevant molecular target.
PHYTOCHEMICAL CONSTITUENTS OF D. ELATA
D. elata is characterized by cardiac glycosides, particularly bufadienolides. 
All the bufadienolides that have been isolated from D. elata are collated 
in Table 2. Kellerman et al. [59,60] argued that bufadienolide containing 
plants are toxic to livestock with an estimated 33% of plant-related 
mortality in cattle in South Africa attributed to this compound. Van 
et al. [61] argued that there is a danger of accidental poisoning or that 
people may be harmed if bulbs of D. elata are used indiscriminately as 
rubbing the bulb scales or leaves on bare skin produces a stinging and 
irritating effect and a skin rash is produced. However, bufadienolides are 
known to have a wide range of biological activities including anti-tumor, 
antiproliferative, and cytotoxic activities [62-68].
Koorbanally et al. [69] identified aromatic acids, 4-hydroxy-3-
methoxybenzoic acid, 3,4-dihydroxybenzoic acid, and trans-3-(4’-
hydroxyphenyl)-2-propenoic acid from the ethyl acetate bulb extract of 
D. elata. Matotoka and Masoko [70] identified flavonoids, phlobatannins, 
saponins, tannins, and terpenoids from the D. elata bulb (Table 3). 
Similarly, Matotoka and Masoko [41] identified alkaloids, flavonoids, 
saponins, steroids, tannins, and terpenoids from a herbal mixture of 
D. elata bulb mixed with leaves of Monsonia angustifolia, Sarcostemma 
viminale and Vahlia capensis, Kirkia wilmsii (leaves, roots, and twigs), 
and Hypoxis hemerocallidea (corm).
Okem et al. [71] argued that D. elata bulbs obtained from the herbal 
medicine informal markets in Pietermaritzburg, KwaZulu-Natal 
Province in South Africa contained high levels of heavy metals, with 
aluminum, cadmium, manganese, and chromium being above the WHO 
recommended safety levels (Table 3). Quantities of mineral elements and 
phytochemical compounds isolated from D. elata are listed in Table 3.
PHARMACOLOGICAL PROPERTIES OF D. ELATA
Pharmacological studies on D. elata bulb and leaf extracts exhibited 
potent in vitro pharmacological activities including acetylcholinesterase 
enzyme inhibitory [2], antibacterial [2,43,50,70-80], antifungal [2,76], 
antimycobacterial [50], anticancer [81], anti-inflammatory [2,72,82,83], 
antioxidant [43,70], hemagglutinating [84], and cytotoxicity [43] activities.
Acetylcholinesterase enzyme inhibitory activities
Ndhlala et al. [2] investigated the acetylcholinesterase enzyme inhibitory 
activities of aqueous bulb extracts of D. elata using the enzyme isolated 
from electric eels with galanthamine as the positive control. The extract 
showed moderate AChE inhibitory activity of 50.0% with half maximal 
inhibitory concentration (IC50) value of 487.4±8.0 µg/mL [2]. The ability 
of D. elata bulb extracts to inhibit acetylcholinesterase shows potential 
therapeutic potential of the species in the management of memory loss 
and neurodegenerative disorders.
Antibacterial activities
Luyt et al. [72] evaluated antibacterial activities of aqueous, ethyl 
acetate, and ethanol bulb and leaf extracts of D. elata against Bacillus 
Fig. 1: Distribution of Drimia elata in tropical Africa
Fig. 2: Number of literature records per medicinal category 
of Drimia elata following the economic botany data collection 
standard [32]
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Medicinal use Parts of the plant used References
Blood and cardiovascular system
Blood purification Bulbs or imbizae phuzwata concoction [2,3,39-42]
Blood purification Bulbs mixed with leaves, roots, and twigs of Kirkia wilmsii 
Engl., Hypoxis hemerocallidea Fisch., C. A. Mey. and 
Avé-Lall. (corms), Monsonia angustifolia E. Mey. ex A. 
Rich. (leaves), and leaves of Sarcostem maviminale (L.) Br. 




Antidiarrheal Bulbs mixed with leaves, roots, and twigs of 
Kirkia wilmsii, Hypoxishem erocallidea (corms), Monsonia 
angustifolia (leaves), and leaves of Sarcostem maviminale, 
and Vahlia capensis
[43]
Constipation Imbizae phuzwata concoction [2,3]
Emetic Bulbs [37,45-47]
General ailments
Angina pain Bulbs [48]
Body pains Imbizae phuzwata concoction [2,3]
Energizing tonic Imbizae phuzwata concoction [2,3]
Fever Bulbs and leaves or bulbs mixed with roots of Artemisia afra 
Jacq. ex Willd., Siphonochilus aethiopicus (Schweinf.) B. L. 
Burtt and Erythrina caffra Thunb.
[45,49,50]
Headache Bulbs [1]
Heart tonic Bulbs [47]
Internal sores Bulbs [41]
Sores Bulbs and leaves [51]
Stress Imbizae phuzwata concoctions [2,3]
Infections and infestations
Gonorrhea Bulbs [19,52,53]
HIV/AIDS opportunistic infections Bulbs or bulbs mixed with twigs of Sarcostemm 
aviminale (L.) R. Br. and roots of Elaeodendron 
transvaalense (Burtt Davy) R. H. Archer, 
Elephantor rhizaelephantina (Burch.) Skeels and 
Zanthoxylumcapense (Thunb.) Harv. and bark of Sclero 
caryabirrea (A. Rich.) Hochst.
[19,53,54]
STIs Bulbs mixed with roots of Elaeodendron transvaalense, 
Elephantor rhizaelephantina (roots), Sarcostemm 
aviminale (twigs), Scleroc aryabirrea (bark), and Zantho 
xylumcapense (root)
[55]
Tuberculosis Bulbs or bulbs mixed with roots of Callilep islaureola DC, 
Croton menyharthii Pax, Senna italica Mill. and bulb of 
Siphonochilus aethiopicus (Schweinf.) B. L. Burtt or bulbs 
mixed with the bark of Warburgi asalutaris (G. Bertol.) 
Chiov. or bulbs mixed with leaves of Ricinus communis L. or 
bulbs mixed with roots of Dicoma anomala Sond. and bulb 
of Eucomis autumnalis (Mill.) Chitt.
[48,50]
Muscular-skeletal system
Arthritis Bulbs and imbizae phuzwata concoction [2,3,39]
Back pain Bulbs [41]
Edema Bulbs [1]
Inflammation Bulbs and leaves [51]
Muscle pain Bulbs [41]
Swelling Bulbs [39]
Pain
Pain Bulbs and leaves or bulb mixed with leaves, roots, and twigs 
of Kirkia wilmsii, Hypoxis hemerocallidea (corm), Monsonia 
angustifolia (leaves), and leaves of Sarcostemma viminale 
and Vahlia capensis
[43,46,51]
Reproductive system and sexual health
Aphrodisiac Imbizae phuzwata concoction or bulbs mixed with 
leaves, roots, and twigs of Kirkia wilmsii, Hypoxis 
hemerocallidea (corm), Monsonia angustifolia (leaves), and 
leaves of Sarcostemma viminale and Vahlia capensis
[2,3,43]




Table 1: Medicinal uses of D. elata
(Contd...)
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subtlis, Escherichia coli, Klebsiella pneumoniae, Micrococcus luteus, 
Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus 
epidermis using disk-diffusion assay with neomycin (2 µg/ml) as the 
positive control. Only ethyl acetate bulb extract was active against 
B. subtlis, K. pneumoniae, M. luteus, P. aeruginosa, and S. aureus with 
inhibition ratios ranging from 0.1 to 0.63 [72]. Ncube et al. [76] evaluated 
antibacterial activities of aqueous, dichloromethane, ethanol, and 
petroleum ether extracts of bulb and leaves of D. elata between spring, 
summer, autumn, and winter seasons against Bacillus subtilis, S. aureus, 
E. coli, and K. pneumoniae using the microdilution bioassay with 
neomycin (μg/ml) as the positive control. The extracts were active in 
all seasons except for winter when the leaves are not available showing 
minimum inhibitory concentration (MIC) values ranging from 0.8 mg/ml 
to >12.5 mg/ml [76]. Ndhlala et al. [2] evaluated the antibacterial 
activities of aqueous, petroleum ether, dichloromethane, and ethanol 
bulb extracts of D. elata against Bacillus subtilis, E. coli, K. pneumoniae, 
and S. aureus using the microdilution bioassay with neomycin as 
the positive control. The extracts showed activities with MIC values 
ranging from 0.8 to >12.5mg/mL [2]. Baskaran et al. [77] evaluated the 
antibacterial activities of ethanol bulb, leaf, shoots, and plantlet extracts 
of in vitro and ex vitro regenerated D. elata in comparison to naturally-
grown plants against S. aureus, Enterococcus faecalis, E. coli, and 
P. aeruginosa using the microdilution method with neomycin (100 µl) 
as the positive control. All extracts exhibited activities with MIC values 
ranging from 0.2 mg/ml to 12.5 mg/ml [77]. Okem et al. [71] evaluated 
antibacterial activities of ethanol stem bulb extracts of D. elata against 
E. coli and S. aureus using microdilution assay with neomycin (2 µg/ml) 
as the positive control. The extracts exhibited activities with MIC values 
ranging from 6.3 mg/mL to 12.5 mg/mL [71]. Okem et al. [78] evaluated 
the effects of cadmium and aluminum accumulation on antibacterial 
activities of ethanol stem bulb extracts of D. elata against E. coli and 
S. aureus using microdilution assay with neomycin (2 µg/ml) as the 
positive control. The control extracts exhibited MIC values of 0.4 mg/ml 
and 0.8 mg/ml against S. aureus and E. coli, respectively, while 
antibacterial activities decreased in extracts exposed to increasing heavy 
metal stress with MIC values ranging from 0.8 mg/ml to 12.5 mg/ml [78]. 
Madisha [50] evaluated the antibacterial activities of ethanol, methanol, 
hydroethanol, and dichloromethane bulb extracts of D. elata against 
Bacillus cereus, E. faecalis, E. coli, Neisseria gonorrhoeae, Proteus vulgaris, 
P. aeruginosa, Shigella flexneri, S. aureus, Staphylococcus epidermidis, and 
Vibrio parahaemolyticus using agar well dilution method and streak plate 
disc diffusion assays. The extracts revealed varying degrees of activities 
with the zone of inhibition values ranging from 8.0 mm to 19.0 mm and 
MIC values ranging from 0.1 mg/mL to 12.5 mg/mL [50]. Madisha [50] 
also evaluated the antibacterial activities of ethanol and hydroethanol 
bulb extracts of D. elata mixed with roots of Elephantorrhiza elephantina 
and leaves of Aloe marlothii and Maurea angolensis against B. cereus, 
E. faecalis, E. coli, N. gonorrhea, P. vulgaris, P. aeruginosa, S. flexneri, S. 
aureus, S. epidermidis, and V. parahaemolyticus using agar well dilution 
method and streak plate disk diffusion assays. The extracts exhibited 
activities against tested pathogens with MIC values ranging from 
0.4 mg/mL to 1.6 mg/mL [50]. Matotoka and Masoko [70] evaluated 
antibacterial activities of acetone and hexane extracts of D. elata bulb 
against S. aureus, E. faecalis, E. coli, and P. aeruginosa using the broth 
Medicinal use Parts of the plant used References
Blocked nose Bulbs or bulbs mixed with roots of Artemisia afra, 
Siphonochilus aethiopicus, and Erythrina caffra
[50]
Chest pains Bulbs and leaves or bulbs mixed with leaves of Lippia 
javanica (Burm. f.) Spreng. or bulbs mixed with roots of 
Artemisia afra, Siphonochilus aethiopicus, and Erythrina 
caffra or bulbs mixed with roots of Elaeodendron 
transvaalense (Burtt Davy) R. H. Archer
[48-50]
Colds Bulbs and leaves [45,46,49]
Cough Bulbs mixed with leaves of Lippia javanica [50]
Expectorant Bulbs [45,47]
Runny nose Bulbs mixed with leaves of Lippia javanica [50]
Ritual or magical uses
Protect households from evil spirits and lightning, and 
also to chase away, ward off or root out evil spirits 
Intelezi herbal concoction [4,45]
Urinary system
Bladder complaints Leaves [1,15,58]
Diuretic Leaves [1,39,47,58]
Kidney problems Imbizae phuzwata concoction [2,3]
Uterus problems Bulbs and leaves [1,15,58]
HIV: Human immunodeficiency virus, AIDS: Acquired immune deficiency syndrome, STIs: Sexually transmitted infections
Table 1: (Continued)
Table 2: Bufadienolides isolated from D. elata bulb using NMR spectroscopy
Bufadienolides Extract References
Proscillaridin A Chloroform: isopropanol [72,73]
Scilliroside Chloroform or chloroform-n-butanol [74]
12β-hydroxyscillirosidin Chloroform or chloroform-n-butanol [74]
12β-hydroxyscilliroside Chloroform or chloroform-n-butanol [74]
Hellebrigenin-3-0-β-glucoside Chloroform or chloroform-n-butanol [74]
16β-hydroxyhellebrigenin Chloroform or chloroform-n-butanol [74]
16β-hydroxyhellebrigenin-3-0-β-glucoside Chloroform or chloroform-n-butanol [74]
5β,16β-dihydroxybufalin-3-O-β-glucoside Chloroform or chloroform-n-butanol [74]





6β-acetoxy-3β,8β,12β,14β-tetrahydroxybufa-4,20,22-trienolide (12β-hydroxyscillirosidin) Dichloromethane [69]
NMR: Nuclear magnetic resonance
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microdilution assay. The extracts exhibited activities against E. faecalis 
and P. aeruginosa with MIC values ranging from 0.6 mg/mL to 2.5 
mg/mL and total activities ranging from 3.3 mL/g to 13.3 mL/g [70]. 
Baskaran et al. [79] evaluated antibacterial activities of the aqueous 
bulb and root extracts of ex vitro grown D. elata derived from somatic 
embryogenesis against Bacillus subtilis, E. faecalis, M. luteus, S. aureus, 
E. coli, K. pneumonia, and P. aeruginosa using microtiter bioassay with 
neomycin (µg/ml) as a positive control. The extracts exhibited activities 
with MIC values ranging from 0.4 mg/ml to 6.3 mg/ml [79]. Kandari 
[80] evaluated antibacterial activities of aqueous, dichloromethane, 
and ethanol bulb extracts of D. elata subjected to vermicompost 
leachate at different concentrations against Bacillus subtilis, S. aureus, 
and E. coli using microdilution assay. The extracts exhibited activities 
with MIC values ranging from 0.4 mg/ml to 6.3 mg/ml [80]. Matotoka 
and Masoko [43] evaluated antibacterial activities of an herbal mixture 
of D. elata bulb together with leaves of M. angustifolia, S. viminale 
and Vahlia capensis, Kirkia wilmsii (leaves, roots, and twigs), and 
Hypoxis hemerocallidea (corm) against Bacillus subtilis, Citrobacter 
braakii, Enterobacter aerogenes, Enterobacter cloacae, E. faecalis, 
E. coli, K. pneumoniae, Leclercia adecarboxylata, Pantoea agglomerans, 
P. aeruginosa, and S. aureus using broth microdilution assay with 
ampicillin (µg/mL) as a positive control. The herbal mixture exhibited 
activities with MIC values ranging from 0.3 mg/mL to >2.5 mg/mL 
[43]. The documented antibacterial activities exhibited by extracts of 
D. elata corroborate the traditional application of the species as herbal 
medicine against bacterial infections causing diarrhea [43], gonorrhea 
[19,52,53], sexually transmitted infections [55], and sores [51].
Antifungal activities
Ncube et al. [76] evaluated antifungal activities of aqueous, 
dichloromethane, ethanol, and petroleum ether extracts of bulb and 
leaf extracts of D. elata between spring, summer, autumn, and winter 
seasons against Candida albicans using the microdilution bioassay 
with amphotericin B (μg/ml) as the positive control. The extracts 
were active in all seasons except for winter when the leaves are not 
available showing MIC and MFC values ranging from 0.4 mg/ml to 
>12.5 mg/ml [76]. Ndhlala et al. [2] investigated the antifungal activity 
of aqueous, petroleum ether, dichloromethane, and ethanol bulb 
extracts of D. elata against C. albicans using the microdilution assay 
with amphotericin B as the positive control. The extracts exhibited 
activities with MIC and MFC values ranging from 3.1 to 6.3 mg/mL and 
6.3 mg/mL to 12.5 mg/mL [2].
Antimycobacterial activities
Madisha [50] evaluated the antimycobaceterial activities of ethanol, 
methanol, hydroethanol, and dichloromethane bulb extracts of 
D. elata against Mycobacterium tuberculosis, Mycobacterium smegmatis, 
Mycobacterium peregrinum, and Mycobacterium haemophilus using 
agar well dilution method and streak plate disc diffusion assays. The 
extracts revealed varying degrees of activities with the zone of inhibition 
values ranging from 9.0 mm to 21.0 mm and MIC values ranging from 
0.1 mg/mL to 12.5 mg/mL [50]. Madisha [50] also evaluated the 
antimycobacterial activities of ethanol and hydroethanol bulb extracts 
of D. elata mixed with roots of Elephantor rhizaelephantina and leaves 
of A. marlothii and M. angolensis against M. tuberculosis, M. smegmatis, 
M. peregrinum, and M. haemophilus using agar well dilution method 
and streak plate disc diffusion assays. The extracts exhibited activities 
against tested pathogens with MIC values ranging from 0.1 mg/mL to 
1.6 mg/mL [50]. These findings show the potential of D. elata in the 
treatment and management of respiratory problems such as blocked 
nose [48], chest pains [46-48], colds [43,44,47], cough [48], and runny 
nose [50].
Anticancer activities
Fouche et al. [81] evaluated in vitro anticancer activities of 
dichloromethane:methane (1:1) of the whole plant of D. elata against a 
panel of three human cell lines (breast MCF7, renal TK10, and melanoma 
UACC62). The extract exhibited total growth inhibition values ranging 
from 6.3 µg/ml to 29.6 µg/ml. The extracts were screened against 
60 human cancer cell lines organized into sub-panels representing 
leukemia, melanoma, cancer of the lung, colon, kidney, ovary, central 
nervous system, breast, and prostate. The extract exhibited total 
Table 3: Mineral and phytochemical composition of D. elata
Mineral and phytochemical composition Values Plant parts References
Aluminum (mg/kg dry weight) 559.8–1595.0 Bulbs [70,71]
Arsenic (mg/kg dry weight) 1.8 Bulbs [71]
Boron (mg/L) 3.0 Bulbs [70]
Cadmium (mg/kg dry weight) 0.01–0.06 Bulbs [71]
Calcium (mg/L) 19.0 Bulbs [70]
Cobalt (mg/L) 0.04 Bulbs [70]
Copper (mg/kg dry weight) 5.6–11.3 Bulbs [71]
Chromium (mg/kg dry weight) 7.8–12.0 Bulbs [71]
Flavonoid (mg of quercetin equivalent/g extract) 0.54–15.0 Bulbs and leaves [43,71,76]
Gallotannin (µg gallic acid equivalent/g dry weight) 4.0–7.0 Bulbs and leaves [76]
Iron (mg/L) 0.15 Bulbs [70]
Iron (mg/kg dry weight) 593.0–1634.0 Bulbs [71]
Lead (mg/kg dry weight) 0.2–1.2 Bulbs [71]
Magnesium (mg/L) 28.0 Bulbs [70]
Manganese (mg/kg dry weight) 60.7–145.8 Bulbs [70,71]
Mercury (mg/kg dry weight) 0.04–0.8 Bulbs [71]
Molybdenum (mg/L) 0.02 Bulbs [70]
Nickel (mg/kg dry weight) 4.2–10.0 Bulbs [71]
Phosphorus (mg/L) 24.0 Bulbs [70]
Potassium (mg/L) 53.0 Bulbs [70]
Silicon (mg/L) 4.0 Bulbs [70]
Sodium (mg/L) 56.0 Bulbs [70]
Sulfur (mg/L) 7.0 Bulbs [70]
Tannin (mg of gallic acid equivalent/g extract) 4.5–9.6 Bulbs and leaves [43,76]
Tin (mg/kg dry weight) 31.4–79.8 Bulbs [71]
Total phenolics (mg gallic acid equivalent/g dry weight) 0.05–2.5 Bulbs and leaves [43,71,76]
Total saponins (mg diosgenin equivalent/g dry weight) 5.0–17.0 Bulbs and leaves [76]
Total steroidal saponin (mg diosgenin equivalent/g dry weight) 1.0–4.5 Bulbs and leaves [76]
Zinc (mg/L) 0.1 Bulbs [70]
Zinc (mg/kg dry weight) 34.1–102.6 Bulbs [71]
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growth inhibition values of 1.1 µg/ml against ovarian (OVCAR-3), 
1.4 µg/ml against central nervous system cancer, CNSC SF-539 and 
1.4 µg/ml against non-small cell lung cancer, NSCLC A549/ATCC [81]. The 
documented anticancer activities may be attributed to bufadienolides as 
these compounds are known to have anticancer activities [62-68].
Anti-inflammatory activities
Luyt et al. [72] evaluated anti-inflammatory activities of aqueous, 
ethyl acetate, and ethanol bulb and leaf extracts of D. elata using the 
cyclooxygenase assay with indomethacin as the positive control. 
The bulb extracts inhibited cyclooxygenase with inhibition ranging 
from 69.0% to 98.0% which was comparable to 94% exhibited by 
indomethacin, the positive control [72]. Stafford et al. [82] evaluated 
anti-inflammatory activities of aqueous, ethanol, and hexane bulb 
extracts of fresh and stored material of D. elata by assessing their ability 
to inhibit cyclooxygenase (COX)-1 enzymes. The ethanol extract showed 
high inhibition level of 96.0% which decreased to 76.0% of the COX-1 
enzyme after 90 days of storage while aqueous extract showed 61.0% 
inhibition which decreased to 0% of the COX-1 enzyme after 90 days of 
storage [82]. Ndhlala et al. [2] investigated the anti-inflammatory effects 
of aqueous, dichloromethane, ethanol, and petroleum ether bulb extracts 
of D. elata using COX-1 and COX-2 inhibitory bioassays. The aqueous and 
ethanol extracts showed percentage inhibition of over 80.0% and 48.0%, 
respectively, for COX-1 while only the aqueous extract showed moderate 
inhibition of over 55.0% for COX-2 enzyme [2]. Ncube et al. [83] evaluated 
the anti-inflammatory activities of aqueous, dichloromethane, ethanol, 
and petroleum ether bulb and leaf extracts of D. elata collected in spring, 
summer, autumn, and winter seasons by assessing their ability to inhibit 
COX-1 and COX-2 enzymes. The dichloromethane and petroleum ether 
bulb and leaf extracts in all seasons except for winter when the leaves 
are not available showed moderate to high inhibition levels ranging from 
58.0% to 94.1% of the COX-1 enzyme. A similar trend was observed for 
COX-2 enzyme with inhibition levels ranging from 52.8% to 91.2% [83]. 
These findings support the traditional use of D. elata as herbal medicine 
for back pain [39], body pains [2,3],inflammation [51], muscle pain [41], 
pain [43,46,51], and swelling [39].
Antioxidant activities
Matotoka and Masoko [70] evaluated antioxidant activities of acetone 
and hexane extracts of D. elata bulb using 2,2-diphenyl-1-picrylhydrazyl 
(DPPH) free radical scavenging assay. The hexane extracts exhibited 
antioxidant activities [70]. Matotoka and Masoko [43] evaluated 
antioxidant activities of an herbal mixture of D. elata bulb together 
with leaves of M. angustifolia, S. viminale and Vahlia capensis, Kirkia 
wilmsii (leaves, roots, and twigs), and Hypoxis hemerocallidea (corm) 
using the DPPH free radical scavenging assay and ferric reducing 
power with L-ascorbic acid as the positive control. The free radical 
scavenging activity showed that the herbal concoction exhibited 
moderate antioxidant activities. The ferric reducing power measuring 
the reduction of Fe3+ to Fe2+ revealed that the herbal concoction 
exhibited good reducing activity compared to L-ascorbic acid, the 
positive control [43]. The documented antioxidant activities of the 
bulb extracts of D. elata are probably due to flavonoids, gallotannins, 
phenolics, saponins, and tannins which have been isolated from the 
species [43,71,76].
Hemagglutinating activities
Gaidamashvili and Van Staden [84] evaluated hemagglutinating 
activities of aqueous bulb extracts of D. elata toward fresh and 
glutaraldehyde-treated rabbit erythrocytes using the hemagglutination 
and hapten inhibition assays. The extracts yielded hemagglutinating 
activity which was detected in the crude protein extracts at the minimal 
concentrations of 19.9 mg/ml. The was inhibited by 200 mM lactose 
along with major inhibition by D(+) trehalose, >DL arabinose, and D 
fructose [84]. The documented information on hemagglutinating 
activities and the identification of proteins from D. elata may be 
useful for future characterization of the species extracts in developing 
pharmaceutical products.
Cytotoxicity activities
Matotoka and Masoko [43] evaluated cytotoxicity activities of an 
herbal mixture of D. elata bulb together with leaves of M. angustifolia, 
S. viminale and Vahlia capensis, Kirkia wilmsii (leaves, roots, and twigs), 
and Hypoxis hemerocallidea (corm) using the 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyl tetrazolium bromide calorimetric assay with 
actinomycin D as the negative control. The cytotoxic concentration 
(CC50) values of all the concoctions were above the highest concentration 
used (1000 μg/mL) and Actinomycin D; the negative control exhibited 
CC50 value of 0.6 μg/mL [43]. The documented cytotoxicity activities 
exhibited by D. elata extracts may be attributed to bufadienolides as 
these compounds are known to have cytotoxicity activities [64,65].
CONCLUSION
Based on information about D. elata that has been documented in this 
review, there appear to be research gaps on ethnopharmacological 
evaluation and clinical research on the species. No in vivo evaluations 
nor an assessment of target-organ toxicity have been carried out 
using the extracts from the species. Since D. elata is widely used in 
combination with other plant species in various herbal concoctions, 
there is a need for extensive research to evaluate synergistic effects 
of the different extracts and also to evaluate their ability to enhance 
the efficiency of the additive mixtures. Future research should also 
focus on aerial parts of the species to ensure full utilization of the 
possible medicinal potential of the species. Literature studies show 
that the major phytochemical compounds isolated from D. elata so far 
are mainly bufadienolides but very little attempt has been made to 
correlate the activities of these compounds with the ethnomedicinal 
uses of the species. Therefore, detailed phytochemical studies of D. elata 
and its pharmacological properties, especially the mechanism of action 
of its bioactive constituents to illustrate the correlation between its 
ethnomedicinal uses and pharmacological activities should be the focus 
of future research studies. Extensive in vivo experiments are required 
to validate the existing pharmacological activities. Since D. elata contain 
potentially toxic compounds, future studies should research on how 
potential toxic components of the species can be managed.
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